We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.Huot, C, Gauthier, M, Lebel, M, et al. Congenital malformations associated with maternal use of Valproic acid. Can J Neurol Sci1987; 14: 290–293.CrossRefGoogle ScholarPubMed
2
2.Lindhout, D, Schmidt, D. ln-utero exposure to valproate and neural tube defects. Lancet1986; 1: 1392–1393.CrossRefGoogle ScholarPubMed
4.Nau, H, Rating, D, Koch, S, et al. Valproic acid and its metabolites; placental transfer, neonatal pharmacokinetics, transfer via mother’s milk and clinical status in neonates of epileptic mothers. J Pharmacol Exp Ther1981; 219: 768–777.Google ScholarPubMed
5
5.Jäger-Roman, , Deichl, A, Jakob, S, et al. Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr1986; 108: 997–1004.CrossRefGoogle ScholarPubMed
6
6.Wolf, H and Leschot, NJ. Prenataal onderzoek naar defecten van de neurale buis bij gebruik van valproinezuur. Ned Tijdschr Geneesk1985; 129: 1891–1892 (summary in English).Google Scholar